Page 78 - AN-1-2

Advanced Neurology NMDA receptors in neuropsychiatric diseases

Cyclin-dependent kinase 5 governs learning and synaptic 164. Ge Y, Dong Z, Bagot RC, et al., 2010, Hippocampal long-
plasticity via control of NMDAR degradation. Nat Neurosci, term depression is required for the consolidation of spatial
10: 880–886. memory. Proc Natl Acad Sci U S A, 107: 16697–16702.
https://doi.org/1038/nn1914 https://doi.org/1073/pnas.1008200107
154. Liu L, Wong TP, Pozza MF, et al., 2004, Role of NMDA 165. Longordo F, Kopp C, Mishina M, et al., 2009, NR2A at CA1
receptor subtypes in governing the direction of hippocampal synapses is obligatory for the susceptibility of hippocampal
synaptic plasticity. Science, 304: 1021–1024. plasticity to sleep loss. J Neurosci., 29: 9026–9041.
https://doi.org/1126/science.1096615 https://doi.org/1523/JNEUROSCI.1215-09.2009
155. Li R, Huang FS, Abbas AK, et al., 2007, Role of NMDA 166. Kalia LV, Kalia SK, Salter MW, 2008, NMDA receptors in
receptor subtypes in different forms of NMDA-dependent clinical neurology: excitatory times ahead. Lancet Neurol,
synaptic plasticity. BMC Neurosci, 8: 55. 7: 742–755.
https://doi.org/1186/1471-2202-8-55 https://doi.org/1016/S1474-4422(08)70165-0
156. Sakimura K, Kutsuwada T, Ito I, et al., 1995, Reduced 167. Berman RM, Cappiello A, Anand A, et al., 2000,
hippocampal LTP and spatial learning in mice lacking Antidepressant effects of ketamine in depressed patients.
NMDA receptor epsilon 1 subunit. Nature, 373: 151–155. Biol Psychiatry, 47: 351–354.
https://doi.org/1038/373151a0 https://doi.org/1016/s0006-3223(99)00230-9
157. Foster KA, McLaughlin N, Edbauer D, et al., 2010, Distinct 168. Murrough JW, Perez AM, Pillemer S, et al., 2013, Rapid and
roles of NR2A and NR2B cytoplasmic tails in long-term longer-term antidepressant effects of repeated ketamine
potentiation. J Neurosci, 30: 2676–2685. infusions in treatment-resistant major depression. Biol
https://doi.org/1523/JNEUROSCI.4022-09.2010 Psychiatry, 74: 250–256.
158. Delaney AJ, Sedlak PL, Autuori E, et al., 2013, Synaptic https://doi.org/1016/j.biopsych.2012.06.022
NMDA receptors in basolateral amygdala principal neurons 169. Preskorn S, Macaluso M, Mehra DO, et al., 2015,
are triheteromeric proteins: Physiological role of GluN2B Randomized proof of concept trial of GLYX-13, an
subunits. J Neurophysiol, 109: 1391–1402. N-methyl-D-aspartate receptor glycine site partial agonist,
https://doi.org/1152/jn.00176.2012 in major depressive disorder nonresponsive to a previous
antidepressant agent. J Psychiatric Pract, 21: 140–149.
159. Morishita W, Lu W, Smith GB, et al., 2007, Activation
of NR2B-containing NMDA receptors is not required https://doi.org/1097/01.pra.0000462606.17725.93
for NMDA receptor-dependent long-term depression. 170. Jiang J, Jiang H, 2015, Efficacy and adverse effects of
Neuropharmacology, 52: 71–76. memantine treatment for Alzheimer’s disease from
https://doi.org/1016/j.neuropharm.2006.07.005 randomized controlled trials. Neurol Sci, 36: 1633–1641.
160. Hendricson AW, Miao CL, Lippmann MJ, et al., 2002, https://doi.org/1007/s10072-015-2221-2
Ifenprodil and ethanol enhance NMDA receptor-dependent 171. Knapp M, King D, Romeo R, et al., 2017, Cost-effectiveness
long-term depression. J Pharmacol Exp Ther, 301: 938-944. of donepezil and memantine in moderate to severe
https://doi.org/1124/jpet.301.3.938 Alzheimer’s disease (the DOMINO-AD trial). Int J Geriatr
Psychiatry, 32: 1205–1216.
161. Gardoni F, Mauceri D, Malinverno M, et al., 2009, Decreased
NR2B subunit synaptic levels cause impaired long-term https://doi.org/1002/gps.4583
potentiation but not long-term depression. J Neurosci, 172. O’Collins VE, Macleod MR, Donnan GA, et al., 2006,
29: 669–677. 1,026 experimental treatments in acute stroke. Ann Neurol,
https://doi.org/1523/JNEUROSCI.3921-08.2009 59: 467–477.
162. Wang D, Cui Z, Zeng Q, et al., 2009, Genetic enhancement of https://doi.org/1002/ana.20741
memory and long-term potentiation but not CA1 long-term 173. Feng B, Morley RM, Jane DE, et al., 2005, The effect of
depression in NR2B transgenic rats. PLoS One, 4: e7486. competitive antagonist chain length on NMDA receptor
https://doi.org/1371/journal.pone.0007486 subunit selectivity. Neuropharmacology, 48: 354–359.
163. Bartlett TE, Bannister NJ, Collett VJ, et al., 2007, Differential https://doi.org/1016/j.neuropharm.2004.11.004
roles of NR2A and NR2B-containing NMDA receptors 174. Auberson YP, Allgeier H, Bischoff S, et al., 2002,
in LTP and LTD in the CA1 region of two-week old rat 5-Phosphonomethylquinoxalinediones as competitive
hippocampus. Neuropharmacology, 52: 60–70.
NMDA receptor antagonists with a preference for the
https://doi.org/1016/j.neuropharm.2006.07.013 human 1A/2A, rather than 1A/2B receptor composition.

Volume 1 Issue 2 (2022) 22 https://doi.org/10.36922/an.v1i2.148